Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 08, 2016 6:11 PM ET

Healthcare Equipment and Supplies

Company Overview of OptiScan Biomedical Corporation

Company Overview

OptiScan Biomedical Corporation develops automated glucose monitoring systems for the intensive care units. The company offers OptiScanner 5000, a bedside blood monitoring platform that provides plasma-based, automated monitoring of patients’ glucose levels without the need for calibration. The company’s OptiScanner 5000 uses a disposable cartridge containing the fluid pathway for sampling, storing, processing, and analyzing blood. OptiScan Biomedical Corporation was founded in 1994 and is based in Hayward, California.

24590 Clawiter Road

Hayward, CA 94545

United States

Founded in 1994





Key Executives for OptiScan Biomedical Corporation

Chairman of the Board, Chief Executive Officer and President
Chief Financial Officer
Chief Operating Officer
Age: 52
Vice President of Research and Development
Vice President of Research & Development
Compensation as of Fiscal Year 2015.

OptiScan Biomedical Corporation Key Developments

Optiscan Biomedical Corporation Introduces its Next-Generation OptiScanner(TM) Product

OptiScan Biomedical Corporation introduced its next-generation OptiScanner(TM) product as part of a special symposium at the 34(th) International Symposium on Intensive Care and Emergency Medicine (ISICEM) being held this week in Brussels, Belgium. The new OptiScanner 6000 will build upon the company's current OptiScanner platform, a first-of-its-kind automated, bedside glucose monitoring system for the ICU, by incorporating the additional ability to monitor key hemodynamic analytes from the same single blood sample. The product will offer real-time monitoring of blood glucose combined with two leading components of cardiac output and oxygenation (hemoglobin and ScvO(2)). These expanded monitoring capabilities are designed to support clinical treatment decisions by providing Critical Care physicians with meaningful information to assess their patients' metabolic and hemodynamic status. The ISICEM symposium, entitled "New Insights into the Metabolic and Hemodynamic Status of the Critically Ill," featured several physician thought-leaders in the area of critical care. The speakers discussed the latest clinical data supporting the role of the current OptiScanner product (OptiScanner 5000) as a continuous glucose monitoring platform for critically ill patients, while also introducing the new OptiScanner 6000 as a first-of-its-kind approach to meeting the real-time, multi-analyte metabolic and hemodynamic monitoring needs of critical care physicians.

Similar Private Companies By Industry

Company Name Region
Vantix Diagnostics, Inc. United States
DJO Finco Inc. United States
MiRTLE Medical LLC United States
CS Medical, LLC United States
PacerView Technologies, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact OptiScan Biomedical Corporation, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at